Company ProfilePremium

Tyro Payments Limited

Company Profile Analysis

Ticker: TYR.AX

ESOMAR 23 Corporate BadgeISO Certifications Badge
Tyro Payments Limited - Company showcase

Year Founded & Workforce

2003

564 Employees

Tyro Payments Limited logo

Tyro Payments Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Tyro Payments Limited Overview

Tyro Payments is Australia's largest independent, domestically focused merchant acquirer and the only payments specialist in the market that also holds a full banking licence. It processes roughly A$44bn a year for about 77,800 merchants, concentrated in small and medium-sized enterprises across hospitality, retail, services and — its standout vertical — healthcare, where Tyro Health integrates Medicare, private-health-fund and pet-insurance claiming with payments. Its competitive identity rests on deep point-of-sale (POS) integration (580+ integrations), a proprietary low-cost acquiring platform, and bundling of payments with a business transaction account, term deposits, cash-flow loans and, since the Thriday acquisition, accounting software. After years of loss-making growth and two failed take-private attempts, the business has been re-engineered into a profitable, cash-generative operator with a ~29% EBITDA margin on gross profit. Its strategic challenge is converting low-single-digit volume growth into faster top-line expansion against the big four banks and global platforms such as Square, Stripe and Adyen.


Company's own description

In its standard boilerplate (FY26 results release, 25 Aug 2026), Tyro describes its founding purpose as making payments the easiest part of doing business, and states that it serves more than 77,800 Australian merchants with in-store, online and on-the-go payment solutions, supported by over 580 integrations across hospitality, retail, services and health, together with integrated banking, lending and accounting. Older ASX boilerplate (2022) characterised Tyro as a technology-focused, values-driven group and as Australia's fifth-largest merchant acquiring bank by terminals, behind the four major banks (Source: Tyro ASX release, 18 Oct 2022; Listcorp company description).

What the company does

Tyro is a merchant acquirer: it contracts with merchants to accept card payments (Visa, Mastercard, eftpos, American Express acceptance, UnionPay/Alipay historically), routes and settles those transactions through its own switching and acquiring platform, and charges a merchant service fee (MSF). Its margin is the MSF less interchange (paid to card issuers) and scheme fees (paid to networks), plus terminal rental and ancillary fees. Because Tyro is itself an ADI, it can settle merchant funds into its own Tyro transaction accounts (often same-day/instantly), take deposits and lend.

Business model and revenue mix

Revenue streamNatureModel classificationCommentary
Merchant service fees (MSF) on card transactionsAd valorem % of TTV or blended pricingUsage-based "service" revenueDominant revenue driver; payments gross profit was A$195.0m of A$220.1m total in FY25 (~89%) (FY25 results release)
Terminal rental and accessory salesMonthly rental per terminal; some hardware salesSubscription / productBundled with MSF; not separately disclosed
Tyro Health claiming/transaction feesPer-claim/transaction fees from practitioners and fundersUsage-based / platformPart of Payments segment
Banking — net interest margin on deposits and loansInterest income on unsecured cash-flow loans; low-cost merchant depositsFinancial servicesBanking GP A$13.4m in FY25 (FY25 release)
Corporate — interest on Tyro's own cash and investmentsTreasury incomeOtherCorporate GP A$11.7m in FY25 (FY25 release)
Accounting/financial-management software (Thriday → "Tyro Accounting")SubscriptionSaaSNew from FY26; size not disclosed

Tyro's economics are almost entirely transaction-based and recurring:

There is no material licensing revenue. Revenue is effectively 100% Australian.

Value-chain position

Tyro sits at the acquirer/processor layer, between merchants (and their POS/practice-management software vendors) and the card schemes and issuing banks. It is vertically integrated across: terminal fleet management (terminals manufactured by third parties — the 2021 outage was linked to Worldline terminal software), switching, acquiring, settlement, and banking. It does not issue consumer cards. Distribution runs through direct sales, POS/software partners (integrations are its moat), ISO partners and, historically, the Bendigo Bank alliance channel.

Customer types and end-markets

SMEs: across hospitality (cafés, restaurants, pubs, clubs), retail, services and trades, automotive, mobile businesses, not-for-profits (tyro.com industry navigation).

Healthcare practitioners: GPs, specialists, dentists, allied health, veterinary (Tyro Health: A$7.9bn TTV in FY26; Allied Health +26%, Dental +19%) (FY26 release).

Enterprise and franchise: newer focus; FY26 wins included Bakers Delight, Lune and Drummond Golf (FY26 release).

eCommerce merchants: eCommerce volumes +25% in FY26 (FY26 release).

Independent characterisation

Tyro is best understood as a scale-constrained, high-quality niche acquirer that has pivoted from a "growth at all costs" fintech to a "profitable compounder" narrative. Its real moats are (1) integration depth in verticals where generic terminals perform poorly (health claiming, hospitality POS with pay-at-table/split bills), and (2) a banking licence that lets it monetise merchant float and lend against card flows. Its weaknesses are a concentrated domestic SME base exposed to discretionary spending, structurally slow TTV growth since FY23 (0.8%, 0.2%, 2.9% in FY24–FY26), and price competition from banks that bundle acquiring with lending, and from global platforms with vastly greater R&D budgets. The business is now as much about gross-profit-per-merchant expansion (banking attach, health, software) as about volume.

Strategy

Stated strategy (FY26 Annual Report / Investor Presentation themes — paraphrased)

  • "Executing the next phase of growth in a $1 trillion payments market" — investment focused on four priority growth opportunities: Health, Banking, Enterprise and eCommerce (FY26 investor presentation).

  • Deepen SME relationships, win more enterprise and franchise customers — sales teams realigned to where Tyro has the "strongest right to win" (FY26 release; presentation).

Payments + banking + software: the integrated proposition: payments as the core, banking and accounting as differentiators that raise customer value and lower churn (H1 FY26 release; FY26 presentation).

Australian home-market advantage: speed, responsiveness, local support and tailored products vs global providers (FY26 release).

Financial discipline and operating leverage: CEO describes Tyro's infrastructure as one of the cheapest in the market, so incremental merchants carry low marginal cost (Proactive interview, Sept 2026).

Inorganic optionality: balance sheet and cash give capacity for organic or inorganic growth (H1 FY26 release); board continues to assess M&A (2025 AGM chair).

Strategic initiatives (last 24 months)

InitiativeTimingDescriptionStatusSource
New banking platform (Tyro Transaction Account)Pilot FY25; launch to new merchants Sept 2025; H1 FY26 formal launchReplatformed business banking with faster settlementLive; transaction accounts +38% in H1 FY26; banking accounts +35% FY26FY25 and H1 FY26 releases
Tyro Flexi LoanH1 FY26New cash-flow loan productLive; originations +19.4% FY26H1 FY26 release
Omnichannel payments upgradesFY25Tyro Pro Key, Embedded Payments, Payment Links, Tyro BYO on AndroidLiveFY25 release
Health product refresh2,026Tyro Health Pro and Pro Lite; GapOnly for vetsLiveFY26 slides; July 2026 media release
Enterprise/franchise pushFY26Wins: Bakers Delight, Lune, Drummond GolfOngoingFY26 release
Thriday acquisition → Tyro AccountingAnnounced Dec 2025; completed FY26Adds accounting/tax/invoicingIntegratingFY26 release; Finovate
Odoo partnershipJul 2025ERP/POS payments integrationLiveMarketScreener
RBA reform readiness2,026Removing surcharging functionality; repricing for interchange cuts; marketing "no-surcharge" simplicityEffective 1 Oct 2026FY26 call; tyro.com blog
Smartpay merger attemptMar–Apr 2025Synergistic cash-and-scrip bidAbandonedBusiness News Australia
Leadership renewalNov 2025–Feb 2026New CEO, COO; CEO joins boardComplete; CFO search openASX releases

Cost programmes

Tyro has not announced a named cost-out programme with a dollar target in the period. Cost discipline is evidenced by: FY25 operating costs down 2.2% (Capital Brief); H1 FY26 operating expenses down 2.9% (H1 FY26 call highlights); operating efficiency (opex/GP) improved from 92% in FY22 to 69% in FY25 (2025 AGM).

Guidance and medium-term targets

Guidance itemFY24 guidanceFY25 guidanceFY26 guidanceFY27 guidance
Normalised gross profit low end (AUD M)206218230240
Normalised gross profit high end (AUD M)215226240255
Actual normalised gross profit (AUD M)210.8220.1231.8—
EBITDA margin guidance low (%)—2828.528.5
EBITDA margin guidance high (%)—2830.030.5
Actual EBITDA margin (%)26.428.028.9—

Sources: FY23 release (FY24 guidance A$206–215m GP, EBITDA A$52–58m); FY24 release (FY25 guidance A$218–226m, ~28%); FY25 release (FY26 A$230–240m, 28.5–30%); FY26 release (FY27 A$240–255m, 28.5–30.5%). FY27 guidance midpoint implies ~6.8% GP growth and EBITDA of ~A$70–78m. Tyro has delivered within its GP guidance range for three consecutive years (FY24–FY26), though FY24 TTV guidance (A$45–47.5bn) was missed (actual A$42.9bn). No formal medium-term (3–5 year) numeric targets are published; the 2025 AGM presentation referenced "medium-term value drivers" (GP growth and EBITDA margin) without published numbers.

Products & Services

Payments segment

ProductDescription / capabilitiesTarget customerLaunch / latestPricing model
Tyro Pro (Pro series EFTPOS terminals)Android-based countertop/portable terminals; integrated EFTPOS, pay@table, split bills, discreet tipping, custom welcome screen, Tap & SaveSMEs, hospitality, retailTyro Pro rolled out FY22; FY24 annual report references Tyro Pro updatesMonthly rental + MSF (simple, blended or cost-plus plans); exact rates on tyro.com merchant-fees page
Tyro Pro KeyNew terminal variant launched FY25 (keypad form factor)SMEs needing PIN-pad style deviceFY25Rental + MSF
Tyro GoMobile Bluetooth card reader/dongleMicro and mobile businessesFY22Hardware purchase + MSF
Tap to Pay / Tyro BYO appAccept contactless payments on iPhone or Android phone without a terminalMobile, micro merchantsiPhone earlier; Android launched FY25MSF only
Integrated EFTPOS / POS integrations580+ integrations with POS and practice-management systems via Tyro SDK and Tyro ConnectMerchants using POS/PMS softwareOngoing; 34 new direct POS integrations in FY25Bundled
Tyro ConnectIntegration hub linking apps (ordering, delivery, loyalty) with POS for hospitalityCafés, QSRs, pubs, clubsLaunched c.FY21—
Embedded PaymentsSDK to embed Tyro acceptance inside third-party software platformsISVs/software partnersFY25Revenue share / MSF
Online payments (eCommerce gateway)Card-not-present acceptance for websitesOmnichannel merchantsOngoing; eCommerce volumes +25% FY26MSF
Payment LinksSend payment requests by link/SMS/emailServices, trades, healthFY25MSF
Tyro App / Merchant PortalReporting, settlement, account managementAll merchantsOngoingFree
Odoo integrationPayment integration with Odoo ERP/POSSMEs on OdooAnnounced July 2025—

Tyro Health (within Payments)

ProductDescriptionTargetLaunchPricing
Tyro Health (ex-Medipass) platformDigital claiming and payments connecting payers (Medicare, private health funds, insurers), providers and patientsMedical, dental, allied health practicesMedipass acquired 2021; Tyro Health unit FY22Per-transaction/claim fees + MSF
Tyro Health Pro (EFTPOS)Health-optimised terminal supporting claims, gap payments, split transactionsAllied health and dentalLaunched 2026Rental + fees
Tyro Health Pro LiteLighter health terminal variantSmaller practicesFY26—
Tyro Health OnlineOnline/telehealth claiming and paymentsPractices with online bookingsReferenced in FY26 presentation—
GapOnly® (veterinary)Pet-insurance claims and payments so owners pay only the gap at the clinicVeterinary clinicsMedia release 22 July 2026—
PMS integrationsIntegration into ~125 practice management systemsHealth practicesCited Sept 2026Bundled

Sources: FY26 release; Investing.com FY26 slides summary; tyro.com media list; Proactive interview with CEO (Sept 2026).

Banking segment

ProductDescriptionTargetLaunchPricing
Tyro Transaction Account (new banking platform)Business transaction account with fast settlement of card takings; replaced legacy Tyro Bank AccountTyro merchantsPiloted FY25, launched to new merchants Sept 2025; formally launched H1 FY26Fee-free / interest features (details on tyro.com)
Term DepositsBusiness term depositsMerchants with surplus cashLong-standingInterest rate offered
Business Loans / Tyro Flexi LoanUnsecured cash-flow loans underwritten against card takings and repaid from settlementMerchants with ≥ established card volumesLending since FY16; Flexi Loan launched H1 FY26Fixed fee/interest; FY26 cashback offer

Banking KPIs: banking accounts +35% (FY26), deposits +27%, loan originations +19.4%; 34% of new merchants chose to bank with Tyro in June 2026 (FY26 release; FY26 slides).

Accounting / financial management

ProductDescriptionTargetLaunchPricing
Tyro Accounting (Thriday platform)AI-powered integrated banking, bookkeeping, tax and invoicing "financial operating system" for small businessesSole traders, micro and small businessesThriday acquired Dec 2025/Jan 2026; Tyro Accounting launched FY26Subscription

Financial Narrative

Income statement

Sources: FY22 results release (29 Aug 2022); FY23 results release and Appendix 4E (29–31 Aug 2023); FY24 release and Appendix 4E (26 Aug 2024); FY25 release (26 Aug 2025); FY26 release and Appendix 4E (25 Aug 2026); revenue FY24 from Business News Australia; FY25/FY26 normalised revenue from FY26 Appendix 4E (via Kalkine); FCF FY25 from Capital Brief. Operating income (EBIT) is not presented consistently by Tyro and is not publicly disclosed in the materials reviewed. FY26 EPS derived, not company-stated.

Source conflicts flagged:

  • FY26 NPAT: Kalkine (citing Appendix 4E) reports statutory NPAT attributable of A$21.319m (+19.7%); Capital Brief reported "net profit after tax A$24.72m", which matches normalised PBT — Capital Brief appears to have mislabelled normalised PBT.

  • FY25 revenue: A$486.1m (normalised, per FY26 Appendix 4E) vs A$487.3m (Capital Brief).

  • FY22 normalised gross profit: A$148.5m per FY23 release; the FY22 release reported payments normalised GP of A$141.5m and group statutory GP of A$154.7m.

Growth rates:

CAGRs: Normalised gross profit FY22→FY26 CAGR ≈ 11.8% (148.5→231.8); FY23→FY26 ≈ 6.3%. Management cites a 14% three-year GP CAGR and ~79–80% three-year EBITDA CAGR to FY25 (FY25 results release/transcript). TTV FY22→FY26 CAGR ≈ 6.7%, but only ≈1.3% FY23→FY26. Revenue CAGR (FY24→FY26, company-reported) ≈ 1.9%.

Commentary — income statement. The five-year record divides into two eras. FY22–FY23 was a volume-led recovery: post-COVID reopening, the Bendigo Alliance's first full year (A$5.2bn TTV in FY22) and inflation lifted TTV 34% then 25%. FY23 was the inflection to profitability, as gross profit rose 30% while operating costs grew far more slowly, taking EBITDA from A$10.7m to A$42.3m. From FY24 onward volumes stalled (TTV growth 0.2%–2.9%) as cost-of-living pressure hit discretionary SME spend and churn rose. Gross profit nonetheless kept growing because of (a) the FY24 "pricing transformation" (repricing plans and passing through scheme costs), (b) banking growth, (c) higher corporate interest income, and (d) health-vertical expansion. Margin expansion since FY24 has been cost-driven: management stated that in FY22 operating expenses consumed 92% of gross profit, versus an operating-efficiency ratio of 69% in FY25 (2025 AGM CEO address). FY26 showed the first re-acceleration of core volume growth (Tyro Core payment volumes +4.4% vs 1.7% in FY25) and an EBITDA margin of 28.9%. The statutory NPAT dip in FY25 (A$17.8m vs A$25.7m) reflects FY24's benefit from tax and Bendigo commission-liability remeasurement effects rather than operating deterioration.

Half-year progression

Sources: H1 FY25 release (26 Feb 2025); H1 FY26 release (24 Feb 2026); H1 FY26 call highlights (FCF A$13.6m, +52%); H1 FY25 TTV derived from +4.0% growth. H1 FY25 FCF derived from the +52% growth figure. Implied H2 FY26 EBITDA was ≈A$27.4m (66.9 − 39.5), reflecting management's flagged H2 investment step-up.

Balance sheet

Tyro is an ADI: its balance sheet contains merchant deposits (liabilities) and merchant loans (assets), so industrial metrics such as "net debt" and "working capital" are of limited meaning.

Sources: FY24 and FY26 Appendix 4E (NTA and exclusions); FY23 Appendix 4E (NTA 0.01); Tyro ASX release 18 Oct 2022 (FY22 deposits/loans); FY23 AGM/release (FY23 deposits A$92.7m, originations A$149.7m).

Additional context: H1 FY26 "available funds" exceeded A$140m (H1 FY26 call highlights). Total debt (short/long split), net debt, goodwill separately, and working capital for each year: not publicly verified in this research. Tyro has no material corporate borrowings disclosed; its funding is merchant deposits and equity.

Implied net tangible assets FY26: ≈A$128m (A$0.24 × ~532m shares) — derived.

Cash flow

Sources: FY24 release (FY23 A$5.7m, FY24 A$30.4m); Capital Brief (FY25 A$19.6m); FY26 release (A$29.4m) and FY26 call (44% conversion). Operating cash flow and capex (including capitalised development) by year were not separately verified. No buybacks have been announced (no buyback authorisation found in ASX announcements reviewed).

Ratios

Derivations: GP/revenue uses company-reported revenue; GP per merchant uses ~76,000 (FY25) and ~77,800 (FY26) merchants.

Indicatively, using the stale Trading Economics equity figure (A$216.8m), FY26 statutory ROE would be ≈10% — treat as indicative only. Cash conversion cycle is not a meaningful metric for an acquirer/ADI. HALO lists ROIC of 11.7% (period unspecified).

Commentary — balance sheet and cash. Tyro's capital story is one of steady de-risking: NTA per share rose from A$0.01 (FY23) to A$0.24 (FY26) as intangibles (largely the Bendigo customer-relationship asset) amortise and retained losses are rebuilt by profits. The business is self-funding, pays no dividend, and holds surplus capital that management explicitly frames as optionality for organic and inorganic growth (H1 FY26 release). The FY25 FCF dip versus FY24 reflects timing, investment and tax effects rather than weaker earnings; FY26 FCF of A$29.4m (44% of EBITDA) re-established the FY24 level. With a market cap near A$357m, FY26 FCF implies a free-cash-flow yield of roughly 8% — a key element of the value case.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Segment Overview

SegmentWhat it containsKey products

Payments

Card acquiring, terminal rental, eCommerce, Tyro Health claiming and payments, embedded payments

Tyro Pro series terminals, Tyro Go, Tap to Pay/BYO app, Payment Links, eCommerce gateway, Tyro Health Pro/Pro Lite, Tyro Health Online, GapOnly (vet), Embedded Payments SDK

Banking

Merchant deposits and lending

Tyro Transaction Account, Term Deposits, Business Loans/Flexi Loan (cash-flow lending)

Corporate (other)

Interest on Tyro's own cash/investments; group costs not allocated

—

(New in FY26) Accounting

—

Tyro Accounting app/portal

Segment gross profit (AUD Mn, normalised)

Segment gross profit (AUD Mn, normalised)FY23FY24FY25FY26

Payments gross profit (AUD Mn)

177.4186.7195.0—

Banking gross profit (AUD Mn)

9.712.613.4—

Corporate gross profit (AUD Mn)

6.011.511.7—

Total gross profit (AUD Mn)

193.2210.8220.1231.8

Segment GP growth and mix

Segment GP growth and mixFY24FY25

Payments GP growth (%)

5.24.4

Banking GP growth (%)

29.46.7

Corporate GP growth (%)

90.21.5

Payments share of total GP (%)

88.688.6

Banking share of total GP (%)

6.06.1

Corporate share of total GP (%)

5.55.3

Segment revenue (AUD Mn; MarketScreener aggregate)

Segment revenue (AUD Mn; MarketScreener aggregate)FY21FY22FY23FY24FY25

Payments revenue (AUD Mn)

229319419472461

Banking revenue (AUD Mn)

3.225.59.3714.7214.78

Corporate and other revenue (AUD Mn)

6.081.7911.1911.4811.66

Income Statement and Margin Analysis (%)

MetricFY22FY23FY24FY25FY26

Total transaction value (AUD Bn)

34.242.642.943.044.3

Revenue, company/press-reported (AUD Mn)

——471.4486.1489.4

Revenue, MarketScreener aggregate (AUD Mn)

326440498486—

Gross profit, statutory group (AUD Mn)

154.7204.3———

Gross profit, normalised (AUD Mn)

148.5193.2210.8220.1231.8

EBITDA, normalised (AUD Mn)

10.742.355.761.666.9

EBITDA margin on gross profit (%)

7.221.926.428.028.9

Profit before tax, normalised (AUD Mn)

-16.14.519.517.724.7

Profit before tax, statutory (AUD Mn)

-29.62.522.417.822.3

Net profit after tax, statutory (AUD Mn)

-29.66.025.717.821.3

Basic EPS, statutory (AUD cents, derived ≈ NPAT / ~525–532m shares)

————4.0

Dividends per share (AUD cents)

00000

Free cash flow (AUD Mn)

—5.730.419.629.4

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Growth metric (%)

Growth metric (%)FY23FY24FY25FY26

TTV growth (%)

24.60.80.22.9

Normalised gross profit growth (%)

30.19.14.45.3

EBITDA growth (%)

295.331.610.68.6

Revenue growth, company-reported (%)

—8.23.10.7

Income Statement and Margin Analysis (%) (Half-Yearly)

Half-year metricH1 FY25H1 FY26

Transaction value (AUD Bn)

22.022.9

Normalised revenue (AUD Mn)

248.3251.1

Normalised gross profit (AUD Mn)

112.0117.6

EBITDA (AUD Mn)

33.039.5

EBITDA margin on GP (%)

29.533.6

Statutory profit before tax (AUD Mn)

10.317.7

Free cash flow (AUD Mn)

9.013.6

Per-Share Data and Key Financials

Balance sheet metricFY22FY23FY24FY25FY26

Net tangible assets per share (AUD)

—0.010.130.190.24

Intangible assets excluded from NTA (AUD Mn)

——59.8—42.6

Right-of-use assets (AUD Mn)

——23.6—13.6

Deferred tax assets, gross (AUD Mn)

——20.4—19.1

Merchant deposits (AUD Mn)

83.392.7———

Loan originations in year (AUD Mn)

99.1149.7———

Cash flow metric (AUD Mn)

Cash flow metric (AUD Mn)FY22FY23FY24FY25FY26

Free cash flow (AUD Mn)

—5.730.419.629.4

FCF conversion of EBITDA (%)

—13.554.631.844.0

Dividends paid (AUD Mn)

00000

Share buybacks (AUD Mn)

00000

Margin Analysis (%) and Key Financials

RatioFY23FY24FY25FY26

EBITDA / gross profit (%)

21.926.428.028.9

Normalised gross profit / revenue (%)

—44.745.347.4

Statutory NPAT / revenue (%)

—5.53.74.4

Gross profit per merchant (AUD K, derived)

——2.902.98

Revenue by Region and Revenue by Region (%)

RegionFY23FY24FY25

Australia revenue (AUD Mn, MarketScreener aggregate)

440498486

Australia share of revenue (%)

100100100

Rest of world revenue (AUD Mn)

000

Vertical / channel growth (%, FY26)

Vertical / channel growth (%, FY26)FY26

Allied Health TTV growth (%)

26

Dental TTV growth (%)

19

eCommerce volume growth (%)

25

Banking accounts growth (%)

35

Group TTV growth (%)

2.9

Share price reference (AUD)

Share price reference (AUD)Value

IPO price, Dec 2019 (AUD)

2.66

All-time high (AUD)

4.53

~Oct 2023 reference (AUD, director buy 24 Oct 2023)

0.93

~Oct 2025 reference (AUD, institutional trades mid-Oct 2025)

1.25

Close 25 Aug 2026 post-results (AUD)

0.80

Close 15 Oct 2026 (AUD)

0.67

Period return (%)

Period return (%)Return

1-year price return to mid-Oct 2026 (%)

-46

3-year price return to mid-Oct 2026 (%)

-28

5-year price return (%, Simply Wall St, as at early 2026)

-64

Since IPO (%)

-75

Valuation Snapshot

MultipleValueBasis

Market capitalisation (AUD Mn)

357

Derived

Trailing P/E, statutory (x)

16.8

FY26 NPAT A$21.3m

Trailing P/E on normalised PBT taxed at 30% (x)

20.7

FY26 normalised PBT A$24.7m × 0.7

Price / gross profit (x)

1.54

FY26 GP A$231.8m

Price / revenue (x)

0.73

FY26 revenue A$489.4m

Price / FCF (x)

12.1

FY26 FCF A$29.4m

Price / NTA (x)

2.8

NTA A$0.24 per share

EV/EBITDA (x)

Not computed

—

EV/Sales (x, fund manager estimate, June 2026)

0.7

Thesis Tracker

FY27E P/GP at guidance midpoint (x)

1.4

A$247.5m

Capital return (AUD cents per share)

Capital return (AUD cents per share)FY22FY23FY24FY25FY26

Dividends per share (AUD cents)

00000

Analyst Conclusions

Management guidance (FY27)

  • Normalised gross profit A$240m–A$255m (growth of ~3.5%–10.0% on FY26's A$231.8m).

  • EBITDA margin 28.5%–30.5% of gross profit (implied EBITDA ~A$68m–A$78m).

  • Management expects continued gross profit growth with strong financial discipline, and cites early FY27 customer wins (FY26 release).

Consensus growth expectations

Simply Wall St's community narrative (Dec 2025) assumed revenue growth of ~2.9% p.a. and net margin ~3.5% — materially more conservative than management's GP guidance, highlighting the gap between revenue and gross-profit growth as interchange pass-through changes.

Bull case

  1. Operating leverage is real and continuing: EBITDA has grown every year since FY22 while gross profit grew 5%–9%; FY27 guidance implies another step-up, and FCF of ~A$29m on a ~A$357m market cap (~8% yield) is unusual for a fintech.

  2. Regulatory reset favours Tyro: The surcharging ban removes the "zero-cost EFTPOS" model that undercut Tyro on price, while transparency rules favour simpler, integrated offerings; several fund managers regard the reform as a net positive.

  3. Strategic value and takeover floor: Tyro has attracted interest from Potentia (up to A$1.60), Westpac, reportedly Stripe, and unnamed parties in 2025 — the current A$0.67 price is far below past bid levels, providing asymmetric upside if corporate activity resumes.

Bear case

  1. Volume growth remains anaemic: TTV growth averaged ~1.3% p.a. from FY23 to FY26, and revenue growth was 0.7% in FY26; gross profit gains have depended on pricing, banking and interest income that may not repeat.

  2. Margin pressure from reforms and competition: Interchange cuts, published fee benchmarks and global competitors (Stripe, Adyen, Square, Shift4/Smartpay) could force MSF reductions, compressing payments gross profit.

  3. Execution and leadership risk: A new CEO (Jan 2026), new COO (Feb 2026) and a departing CFO (Sept 2026) must execute a multi-front strategy (Health, Banking, Enterprise, eCommerce, accounting software) with limited scale and R&D resources.

Catalysts and monitorables (next 12 months)

Catalyst / monitorableExpected timingWhy it matters
Q1 FY27 trading update / 2026 AGMNov 2026First read on post-surcharge-ban pricing and volumes
CFO appointmentH2 CY2026–H1 CY2027Continuity of capital management
H1 FY27 resultsLate Feb 2027Progress versus A$240–255m GP guidance; EBITDA margin trajectory
RBA foreign-card interchange cap and enhanced statements1 Apr 2027Further pricing/transparency changes
RBA consultation on wallets, Amex, BNPL, eCommerce platforms2026–2027Potential further regulatory change
Banking attach and deposit growthOngoingKey GP-per-merchant driver
Tyro Health growth (Allied Health, Dental, vet)OngoingHighest-growth vertical
Thriday/Tyro Accounting adoptionOngoingEvidence of multi-product strategy
Capital management (dividend/buyback initiation or M&A)OngoingUse of surplus capital
Corporate approachesUnpredictablePotential premium realisation
FY27 resultsLate Aug 2027Guidance delivery

Analyst verdict

Tyro Payments has completed one of the more convincing turnarounds among ASX fintechs. Between FY22 and FY26, normalised gross profit rose from A$148.5m to A$231.8m, EBITDA from A$10.7m to A$66.9m, and statutory results swung from a A$29.6m loss to a A$21.3m profit, with free cash flow of A$29.4m in FY26. Management has met gross-profit guidance three years running, and the balance sheet is ungeared with rising tangible equity. On almost any cash-flow measure, the shares — at roughly A$0.67, a ~A$357m market capitalisation, ~12x free cash flow and ~1.5x gross profit — look inexpensive.

The market's scepticism, however, is rational rather than careless. Transaction value has barely grown since FY23, revenue is essentially flat, and much of the gross-profit progress has come from repricing, banking float and treasury income rather than share gains. The RBA's surcharging ban and interchange cuts, effective October 2026, introduce genuine uncertainty about merchant pricing, and Tyro competes against banks and global platforms with far greater scale and investment capacity. Leadership turnover — a new CEO in January 2026 and the CFO's resignation in September — adds execution risk at a pivotal moment.

On balance, the investment case rests on three questions: whether Tyro can re-accelerate core volumes (FY26's 4.4% core volume growth is encouraging), whether multi-product adoption (banking, health, accounting) lifts gross profit per merchant materially, and whether the board will either return surplus capital or engage with a credible bidder at a price closer to historical offers. The FY27 guidance (A$240–255m GP, 28.5–30.5% EBITDA margin) is a reasonable bar. We regard Tyro as an undervalued, cash-generative but low-growth niche operator, with upside skewed by strategic optionality and downside cushioned by profitability; delivery of mid-to-upper FY27 guidance alongside a CFO appointment and a capital-management decision would likely be required for a sustained re-rating.


APPENDIX: KEY SOURCES

  • Tyro FY26 results media release (tyro.com / ASX) — 25 Aug 2026 — FY26 headline results, guidance, wins, health/banking KPIs

  • Tyro 2026 Annual Report / Appendix 4E (ASX) — 25 Aug 2026 — TTV, PBT, NPAT, NTA, revenue, dividend

  • Tyro FY26 Investor Presentation (ASX) — 25 Aug 2026 — Strategy themes, A$1tn market, banking metrics

  • FY26 results call transcript (Investing.com) — 25 Aug 2026 — Core volume growth, FCF conversion, health growth

  • Appointment of Managing Director (ASX) — 25 Aug 2026 — Lee board appointment

  • Tyro H1 FY26 results release (ASX/tyro.com) — 24 Feb 2026 — H1 FY26 results

  • Tyro FY25 results release, Annual Report, presentation, transcript — 26 Aug 2025 — FY25 results and segment GP

  • 2025 AGM addresses and presentation (ASX) — 26 Nov 2025 — Operating efficiency, guidance reaffirmation

  • Tyro FY24 results release and Annual Report — 26 Aug 2024 — FY24 results, FY23 restated segment GP

  • Tyro FY23 results release, Appendix 4E, presentation — Aug 2023 — FY23 results, FY22 comparatives

  • Tyro FY22 results release and presentation — 29 Aug 2022 — FY22 results

  • RBA Review of Merchant Card Payment Costs and Surcharging — Conclusions Paper — 31 Mar 2026 — Regulatory reform details

  • Capital Brief; Business News Australia; Reuters (Stockopedia); Motley Fool; Kalkine; Stockhead; IG; ShareCafe; Finovate; Listcorp; Morningstar — 2020–2026 — Event chronology, takeover history, executive changes, share price

  • Aggregators: MarketScreener, Trading Economics, StockAnalysis, Market Index, InvestSMART, Simply Wall St, HALO, IBISWorld — 2025–2026 — Flagged supplementary data (segments, employees, auditor, share prices, holders)

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Executive Leadership Team

NameTitleTenurePrior roles / backgroundEducationSource

Nigel Lee

CEO (from 12 Jan 2026); Managing Director and director (from 31 Aug 2026)

<1 year

Global Chief Customer Officer and Head of Asia Pacific, Ingenico (led commercial strategy across 100+ countries); senior roles at DataMesh Group, American Express, First Data, MoneyGram; operating partner at APIS Partners (fintech PE); board adviser to fintech start-ups; relocated from Singapore

Reported MEng, Chemical Engineering, Imperial College London (single aggregator source)

tyro.com leadership page; Capital Brief; InvestSMART; TheOfficialBoard

Emma Burke

CFO (resigning)

Joined Oct 2024; resignation announced 29 Sep 2026 (leaving for Built Living CFO role); acting CEO 5 Dec 2025–12 Jan 2026

25+ years leading finance teams in consumer goods and property

—

tyro.com; Listcorp; ShareCafe

Andrew Chanmugam

Chief Operating Officer

Joined Feb 2026

——

tyro.com

Steve (surname not confirmed in sources)

Chief Technology Officer

Joined Aug 2024

——

tyro.com

Adriano (surname not confirmed in sources)

CEO, Tyro Health

Joined May 2021 via Medipass acquisition; leads Tyro Health since Oct 2022

Medipass leadership

—

tyro.com

Monica Appleby

Chief People and Communications Officer

Joined 2020; CPCO since 2021

KPMG, Deloitte, Tabcorp (Australia and UK)

—

tyro.com

Chief Risk Officer (name not shown in retrieved text)

CRO

Joined Mar 2019; CRO since 10 Jun 2021

——

tyro.com

Sami Wilson

General Counsel

Since c.2017

——

MarketScreener

Jairan Amigh

Special Counsel & Company Secretary

Since 2020

——

MarketScreener; AGM transcript

Michael Nuciforo

Thriday founder/CEO; joined Tyro

From Jan 2026

Founder, Thriday

—

Finovate

“—” = not publicly disclosed.

Board of Directors

DirectorRoleAppointedBackground / other rolesAge (if disclosed)Source

Fiona Pak-Poy

Independent Non-Executive Chair

Director Sep 2019; Chair from Feb/Mar 2023

30+ years in technology, finance, government and NFP; director of HMC Capital (from Nov 2024); prior chair roles in private companies

—

InvestSMART; MarketScreener; Business News Australia

Nigel Lee

CEO & Managing Director

31 Aug 2026

See above

—

ASX release 25 Aug 2026

Paul Rickard

Independent Non-Executive Director

2009 (longest-serving)

Not detailed in sources reviewed

—

InvestSMART

Aliza Knox

Independent Non-Executive Director

21 Apr 2021

Not detailed in sources reviewed (ex-tech executive per prior knowledge)

~65 (aggregator)

MarketScreener

Claire Hatton

Independent Non-Executive Director

5 Jan 2022

Seven years on Google Australia's commercial leadership team; NED roles; co-founder Full Potential Labs

~54 (aggregator)

FNN, Jan 2022

Shefali Roy

Independent Non-Executive Director

5 Jan 2022

Former COO and CCO of TrueLayer; senior roles at Stripe, Apple, Christie's, Goldman Sachs; teaches at Oxford Saïd

—

FNN, Jan 2022

Steven Holmes

Independent Non-Executive Director

3 Jun 2025

Not detailed in sources reviewed

~46 (aggregator)

MarketScreener; AGM transcript

“—” = not publicly disclosed.

Directors' Remuneration

ItemDetailSource

Nigel Lee fixed annual remuneration

A$830,000, plus STI and LTI subject to performance; no change on appointment as MD

ASX release 5 Nov 2025 (via InvestSMART); ASX release 25 Aug 2026

Jon Davey FY26 pro-rated STI

A$169,000 (67% of on-target)

ShareCafe, 26 Nov 2025

Jon Davey equity treatment

267,857 of 297,619 FY21 Medipass service rights accelerated/pro-rated; FY23 LTI: 586,548 vested, 695,503 lapsed; >2.5m FY24/FY25 LTI rights cancelled

ShareCafe

Major Shareholders

HolderStake / latest movementStatusSource

Spheria Asset Management

Bought 28.3m shares Aug 2025; further trades Sept 2025

—

Simply Wall St insider log

Macquarie Group entities

Increased stake Oct and Dec 2025

—

Simply Wall St; MarketScreener (23 Dec 2025)

Pinnacle Investment Management

Purchases June–July 2025

Substantial holder at the time

Simply Wall St

The Vanguard Group

Increased Aug 2025

Substantial holder at the time

Simply Wall St

Aware Super

Bought July 2025; sold ~0.9m Nov 2025

Movement disclosed

Simply Wall St

Regal Partners

Ceased to be substantial holder 22 Jul 2026

Exited

Kalkine

Grok Ventures (Mike Cannon-Brookes)

Significant holder in 2022 (voting deed with Potentia at A$1.27)

—

IG (Dec 2022)

Top-10 list with exact %

Not publicly verified in this research — refer FY26 Annual Report shareholder information section

——

Competitive Landscape

Key Competitors

CompetitorSegment(s) competingDescriptionRelative positioning vs Tyro

Commonwealth Bank (CBA)

Acquiring, SME banking

Largest Australian merchant acquirer (incl. Smart terminals, Square-like products)

Far larger; bundles lending/banking; Tyro competes on integration/service

Westpac

Acquiring, SME banking

Big-four acquirer; explored buying Tyro in 2022

Larger; less vertical depth

NAB

Acquiring, health (HICAPS), SME banking

Big-four; owns HICAPS, the incumbent in health claiming

Direct competitor to Tyro Health

ANZ

Acquiring, SME banking

Big-four; Worldline JV for acquiring

Larger

Block (Square)

SME acquiring, software

Global; strong in micro-merchants and POS software

Larger, software-led; flat-rate pricing

Stripe

eCommerce, enterprise, embedded

Global online leader; reported interest in Tyro (2025)

Dominant online; weaker in-store health

Adyen

Enterprise omnichannel

Global unified-commerce acquirer

Dominant in large enterprise

Zeller

SME acquiring + business accounts

Australian fintech with payments + banking-style accounts

Closest like-for-like challenger

Smartpay (now Shift4)

SME EFTPOS (AU/NZ)

Zero-cost EFTPOS surcharging model; acquired by Shift4 2025

Direct SME competitor; surcharge ban affects its model

Windcave

Unattended, hospitality, eCommerce

ANZ-origin gateway/acquiring tech

Niche overlap

Fiserv/First Data, Global Payments, Worldline

Acquiring/processing

Global processors active in AU

Partners/competitors

Lightspeed, Square, Toast-type POS-embedded payments

POS-embedded payments

POS vendors internalising payments

Threat to integration moat

Peer Comparison FY2026

MetricTyro (FY26, AUD)Block (FY2024, USD)Adyen (FY2024, EUR)

Revenue / net revenue

A$489.4m revenue

——

Growth

GP +5.3%

——

Margin

EBITDA/GP 28.9%

Not comparable basis

—

R&D intensity

—

High (tech-led)

High

Market share in Australia

Not disclosed (5th-largest acquirer by terminals per older boilerplate)

——

“—” = not publicly disclosed.

Company Snapshot

564

Employees

2003

Founded

Sydney, Australia

Headquarters

SWOT Analysis

Strengths

  • Proven margin expansion: EBITDA/GP rose from 7.2% (FY22) to 28.9% (FY26); EBITDA from A$10.7m to A$66.9m (FY22–FY26 releases).
  • Guidance credibility: Gross profit within guidance for FY24, FY25 and FY26 (A$210.8m vs 206–215; A$220.1m vs 218–226; A$231.8m vs 230–240).
  • Cash generation: FCF A$29.4m in FY26 (+49.5%), 44% conversion; implied ~8% FCF yield at current market cap.
  • Health franchise: A$7.9bn TTV, Allied Health +26%, Dental +19% in FY26; ~125 PMS integrations.
  • Banking licence and attach: 34% of new merchants banking with Tyro (June 2026); banking accounts +35%, deposits +27%, originations +19.4% (FY26).
  • Integration network: 580+ integrations; 34 new direct POS integrations in FY25.
  • Debt-free, improving tangible equity: NTA per share up from A$0.01 (FY23) to A$0.24 (FY26).

Weaknesses

  • Low volume growth: TTV +0.8% (FY24), +0.2% (FY25), +2.9% (FY26).
  • Revenue stagnation: Revenue +0.7% in FY26 (A$489.4m vs A$486.1m).
  • Undiversified geography: 100% Australian revenue.
  • Small scale vs competitors: ~A$44bn TTV vs big-four and global platforms; limited R&D budget.
  • Reliance on non-IFRS measures: Normalised GP and EBITDA exclude Bendigo Alliance accounting and share-based payments, complicating peer comparison.
  • Management turnover: Three CEOs since 2022 (Cooke → Davey → Lee) and CFO resignation in Sept 2026.

Opportunities

  • RBA reform: Surcharging ban from 1 Oct 2026 could favour transparent, simple pricing and challenge surcharge-model rivals (fund manager commentary, June 2026).
  • Health and vet expansion: GapOnly vet launch (July 2026); health market ~A$110bn.
  • Multi-product monetisation: Thriday/Tyro Accounting plus banking raises GP per merchant (FY26 release).
  • Enterprise and franchise: Bakers Delight, Lune, Drummond Golf wins (FY26).
  • eCommerce/omnichannel: eCommerce volumes +25% (FY26).
  • Corporate activity: Repeated takeover interest (2022–2026) provides valuation support and potential premium realisation.

Threats

  • Price competition post-reform: Interchange cuts plus transparency obligations may compress MSF margins (RBA Conclusions Paper).
  • Big-bank bundling: Major banks can cross-subsidise acquiring with lending/deposit relationships.
  • Global platforms: Stripe, Adyen and Square invest heavily in Australia; Shift4 now owns Smartpay.
  • Embedded payments disintermediation: POS/software vendors internalising payments could erode Tyro's integration moat.
  • Operational/cyber risk: 2021 outage precedent; class action settled for A$5m.
  • Macroeconomic softness: SME discretionary spending weakness affected FY24–FY25 volumes.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
Apr 2025AFR reports Stripe held preliminary talks with Tyro Kalkine (citing AFR)Signals strategic interest; unconfirmed
Apr 2025Tyro exits Smartpay process after Shift4's NZ$1.20 cash offer Business News AustraliaFailed inorganic scale move
4 Jun 2025CEO Jon Davey announces he will step down MarketScreenerLeadership uncertainty
3 Jun 2025Steven Holmes joins board MarketScreenerBoard renewal
Jun–Aug 2025Pinnacle, Vanguard, Aware Super, Spheria build stakes Simply Wall StInstitutional accumulation
14 Jul 2025Tyro welcomes RBA update on surcharging review; Odoo partnership announced MarketScreenerRegulatory positioning; channel
12–13 Aug 2025Trading halt; confirms unsolicited approaches from separate parties Reuters; Capital BriefTakeover premium in share price (to ~A$1.16)
26 Aug 2025FY25 results: GP A$220.1m (+4.4%), EBITDA A$61.6m, NPAT A$17.8m (−31%); FY26 guidance A$230–240m FY25 release; Capital BriefShares fell ~5% intraday
Sep 2025New banking platform rolled out to new merchants FY25 releaseBanking growth driver
22 Oct 2025Notice of 2025 AGM ASXGovernance
5 Nov 2025Nigel Lee appointed CEO (from 12 Jan 2026), A$830k fixed pay InvestSMARTSuccession resolved; shares later fell sharply from ~A$1.07
26 Nov 2025AGM: FY26 guidance reaffirmed; Q1 FY26 core volumes +6% AGM release; Capital BriefPositive trading update
26 Nov 2025Davey exit terms: pro-rated STI A$169k; rights treatment ShareCafeRemuneration
5 Dec 2025Davey departs; CFO Burke acting CEO ShareCafeInterim leadership
15 Dec 2025Agreement to acquire Thriday Finovate; Startup DailySoftware expansion
23 Dec 2025Macquarie increases stake MarketScreenerHolder movement
12 Jan 2026Nigel Lee starts as CEO ASXNew strategy owner
Feb 2026Andrew Chanmugam appointed COO tyro.comExecutive build-out
24 Feb 2026H1 FY26: GP A$117.6m (+5.0%), EBITDA A$39.5m (+19.8%), statutory PBT A$17.7m (+72%); guidance reaffirmed H1 FY26 releaseStrong half
Mar 2026Regal Partners substantial-holder notice (10 Mar) KalkineHolder movement
31 Mar 2026RBA Conclusions Paper: surcharging ban and interchange cuts; Tyro welcomes; shares rose up to ~14% intraday Tyro media release; InvestSMARTRegulatory clarity, seen as net positive
Apr 2026Strategy communication
May 2026Shares recover ~21% on renewed corporate-activity speculation (DMX fund report) Thesis TrackerTakeover premium
29 Jun 2026Bakers Delight win announced tyro.com mediaEnterprise/franchise proof point
22 Jul 2026GapOnly launched for vet clinics; Regal Partners ceases to be substantial holder tyro.com; KalkineHealth extension; register change
18 Aug 2026Results date notice Kalkine—
25 Aug 2026FY26 results: GP A$231.8m (+5.3%), EBITDA A$66.9m (+8.6%), statutory NPAT A$21.3m, FCF A$29.4m (+49.5%); FY27 guidance A$240–255m; no dividend FY26 release; KalkineDelivered guidance; shares fell ~8% to A$0.80
25 Aug 2026Nigel Lee appointed Managing Director (effective 31 Aug) ASX via WebullGovernance
25 Aug 2026Morningstar: shares undervalued; outlook better than price suggestsAnalyst support
11–23 Sep 2026Director salary-sacrifice share issues; on-market buys by Pak-Poy and Knox Motley Fool; KalkineInsider buying signal
23 Sep 2026CEO presents at ASX SMIDcaps Conference Yahoo/ProactiveInvestor engagement
29 Sep 2026CFO Emma Burke resigns (to Built Living) ListcorpKey-person change
30 Sep 2026Options (A$1.79 exercise price) expire KalkineCapital structure
1 Oct 2026RBA surcharging ban and lower interchange caps take effectStructural pricing change
7–12 Oct 2026Performance rights converted; 533.1m shares quoted Kalkine; TipRanksCapital structure

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

4 charts
Income Statement: Revenue & Gross Profit: Revenue, company/press-reported rose from AUD 471.4 Bn in FY2024 to AUD 489.4 Bn in FY2026.
Tyro Payments Limited — Income Statement: Revenue & Gross Profit
Series (AUD Bn)FY2022FY2023FY2024FY2025FY2026
Revenue, company/press-reported——471.4486.1489.4
Revenue, MarketScreener aggregate326440498486—
Gross profit, statutory group154.7204.3———
Gross profit, normalised148.5193.2210.8220.1231.8

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.